Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Specialty PACS Market, by Deployment Model
1.4.2 Europe Specialty PACS Market, by Type
1.4.3 Europe Specialty PACS Market, by End User
1.4.4 Europe Specialty PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. Europe Specialty PACS Market by Deployment Model
4.1 Europe On premises Market by Country
4.2 Europe Cloud-based Market by Country
Chapter 5. Europe Specialty PACS Market by Type
5.1 Europe Radiology PACS Market by Country
5.2 Europe Orthopedics PACS Market by Country
5.3 Europe Oncology PACS Market by Country
5.4 Europe Pathology PACS Market by Country
5.5 Europe Ophthalmology PACS Market by Country
5.6 Europe Women’s health PACS Market by Country
5.7 Europe Other Type Market by Country
Chapter 6. Europe Specialty PACS Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Ambulatory Surgical Centers Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Specialty PACS Market by Country
7.1 Germany Specialty PACS Market
7.1.1 Germany Specialty PACS Market by Deployment Model
7.1.2 Germany Specialty PACS Market by Type
7.1.3 Germany Specialty PACS Market by End User
7.2 UK Specialty PACS Market
7.2.1 UK Specialty PACS Market by Deployment Model
7.2.2 UK Specialty PACS Market by Type
7.2.3 UK Specialty PACS Market by End User
7.3 France Specialty PACS Market
7.3.1 France Specialty PACS Market by Deployment Model
7.3.2 France Specialty PACS Market by Type
7.3.3 France Specialty PACS Market by End User
7.4 Russia Specialty PACS Market
7.4.1 Russia Specialty PACS Market by Deployment Model
7.4.2 Russia Specialty PACS Market by Type
7.4.3 Russia Specialty PACS Market by End User
7.5 Spain Specialty PACS Market
7.5.1 Spain Specialty PACS Market by Deployment Model
7.5.2 Spain Specialty PACS Market by Type
7.5.3 Spain Specialty PACS Market by End User
7.6 Italy Specialty PACS Market
7.6.1 Italy Specialty PACS Market by Deployment Model
7.6.2 Italy Specialty PACS Market by Type
7.6.3 Italy Specialty PACS Market by End User
7.7 Rest of Europe Specialty PACS Market
7.7.1 Rest of Europe Specialty PACS Market by Deployment Model
7.7.2 Rest of Europe Specialty PACS Market by Type
7.7.3 Rest of Europe Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:
Unique Offerings 
